- men’s pelvic health and erectile dysfunction
- women’s pelvic health and postpartum recovery
- Chronic Pelvic Pain Syndrome
Non-invasive recovery technology
We bring advanced non-invasive technology to market
- Technology◆
- Standards◆
- Training◆
- Access◆
- Non-invasive recovery technology◆
Who we are
We equip hospitals and clinics with advanced non-invasive recovery technology, then build the standards, trained teams and financing that make it deliver.
One accountable partner for the technology, the protocols, the trained team and the financing.
We provide custom solutions, after-sales service and technical support for healthcare partners.
- Scope
- — Protocol, indication mapping, outcome tracking
- Support
- — Custom solutions, after-sales service, technical support
- Output
- — A department that runs without us in the room
Clinical training and certification for individual practitioners and for the unit as a whole, delivered by clinicians who run these protocols daily in our own sites.
- Format
- — On-site and Centre of Excellence
- Result
- — Certified practitioners, certified department
We make the technology financially reachable for hospitals and clinics through our leasing partners & facilities, and flexible business models.
Capability
What we do
- 01
Technology
Proven non-invasive systems, sourced, installed and serviced.
- 02
Standards
Treatment protocols and department design, not just equipment.
- 03
Training
Centre of Excellence certification for practitioners and units.
- 04
Access
Leasing, revenue share and staged acquisition models.
Disciplines
Medical focus categories
Five disciplines, each mapped to an established hospital department with defined indications, trained staff and measurable outcomes.
- tissue regeneration
- pain and injury recovery
tendinopathiesplantar fasciitismyofascial paincalcifications
- bone healing
- joints and soft tissue care
- persistent MSK pain
- chronic tendon degeneration
- preventive bone and joint care
- diabetic wound care
- general trauma
- surgical risk
- pressure injuries
Clinical studies
Evidence, published.
Selected trials and reviews on focused shockwave therapy, grouped by the disciplines we work in. Every entry links to the original publication.
Pain management · Piezoelectric shockwave device
Efficacy of extracorporeal shockwave therapy in the treatment of postherpetic neuralgia
Authors’ conclusion: shockwave therapy delivered with a Richard Wolf Piezo Shockwave² device significantly reduced pain and itch associated with postherpetic neuralgia.
Clinical study13 patientsPiezo Shockwave²
- Chronic pelvic painRandomised controlled trial2013Efficacy of Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome: A Randomized, Controlled Trial
- Chronic pelvic painSystematic review2026Safety and Efficacy of Extracorporeal Shock Wave Therapy for the Management of Chronic Pelvic Pain Syndrome: A Systematic Review
- Erectile dysfunctionRandomised, sham-controlled trial2019Erectile Dysfunction Treatment Using Focused Linear Low-Intensity Extracorporeal Shockwaves: Single-Blind, Sham-Controlled, Randomized Clinical Trial
- Erectile dysfunctionMeta-analysis2025Efficacy of low-intensity extracorporeal shock wave therapy for erectile dysfunction: updated meta-analysis of randomized trials
- Post-prostatectomyRandomised, sham-controlled trial2022Linear Low-Intensity Extracorporeal Shockwave Therapy as a Method for Penile Rehabilitation in Erectile Dysfunction Patients after Radical Prostatectomy: A Randomized, Single-Blinded, Sham-Controlled Clinical Trial
- Peyronie’s diseaseSystematic review and meta-analysis2024Low-intensity extracorporeal shock wave therapy for Peyroniès disease: a systematic review and meta-analysis
- Diabetic foot ulcerRandomised controlled trial2014Efficacy of shock wave therapy on chronic diabetic foot ulcer: A single-blinded randomized controlled clinical trial
- Diabetic foot ulcerPilot randomised trial2025Extracorporeal Shockwave Therapy for Diabetes Related Foot Ulcers: A Pilot Three-Arm Double-Blinded Randomised Controlled Trial
- Tennis elbowFocused shockwave, randomised controlled trial2024Focused shock wave and ultrasound therapies in the treatment of lateral epicondylitis - a randomized control trial
- Plantar fasciitisPiezoelectric focused waves2018Piezoelectric focal waves application in the treatment of plantar fasciitis
- Calcific shoulderPlacebo-controlled studyExtracorporeal Shock Wave Therapy for the Treatment of Chronic Calcifying Tendonitis of the Rotator Cuff
- Post-surgical recoveryOpen-label randomised trial2025Effect of Early Extracorporeal Shockwave Therapy on Postoperative Pain and Functional Recovery After Intramedullary Nailing: An Open-Label Randomized Controlled Trial
- Achilles tendinopathyDouble-blind randomised trialShockwave therapy for chronic Achilles tendinopathy - Double-blind, randomized clinical trial of efficacy
- Plantar fasciitisClinical study, 2-year follow-upExtracorporeal shockwave therapy (ESWT) in patients with chronic proximal plantar fasciitis: a 2-year follow-up
Technology platform
PiezoWave²
Piezoelectric focused shockwave technology with adjustable penetration depth and plug-and-play therapy sources. Full specifications are published by the manufacturer.
Explore PiezoWave² at Elvation- 20
- Intensity levels
- 5M
- Pulses, source lifespan
Manufactured by Richard Wolf, distributed by Elvation. Specifications as stated by the manufacturer.
Selected from the manufacturer's library of piezoelectric shockwave studies. Outcomes depend on the device, indication and protocol. Indications and availability vary by country.
Reference guidelines: ISMST Guidelines for ESWT
Spotlight of the Month
Focused shockwave for pelvic health
-
PiezoWave²T
Piezo shockwave platform. Single- and double-layer therapy sources, T-Mode treatment concept.
-
BASIC range
For all single-layer therapy sources. High-voltage generator, integrated source holder, equipment trolley.
Single-layer -
MULTIUSE range
Ready for all single- and double-layer therapy sources, with holders for two additional sources.
Single + double-layer -
Therapy sources
Indication-specific focal zones, freely selectable. Penetration depth adjusted incrementally.
Full range -
F7G3
Light and handy. Superficial structures — hand, shoulder, foot, ankle.
0.403 mJ/mm² · 0–30 mm -
F10G4
The allrounder. Versatile across pathologies needing 5–40 mm in the central focal zone.
0.822 mJ/mm² · 5–40 mm -
F10G10
Deep penetration with elongated focal zone. Trigger points in hip and buttock, pelvic floor.
0.323 mJ/mm² · 10–100 mm
Network
Trusted by KPJ, IHH group and access to over 200+ hospitals across Malaysia
- 200+
- Hospitals across Malaysia
- KPJ
- Hospital group
- IHH
- Hospital group
- 5
- Medical focus categories
Partnership
Build the
future
with us
Capital shouldn’t decide who gets good care
hello@carehaus.healthKuala Lumpur — operating internationally